MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.

May 15, 2012 by MassDevice staff

Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on a Goldman upgrade and the SEC closes a probe of Zoll's Middle East sales just ahead of $2.3B Asahi merger.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

3. SEC closed probe of Zoll's Middle East sales just ahead of $2.3B Asahi merger

Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange Commission shut the books on a review of Zoll Medical's sales to Iran, Syria and other countries the U.S. deems "state sponsors of terrorism."

Read more

Sign up to get our free newsletters delivered straight to your inbox

Comments